Superior Accuracy of Aspergillus Plasma Cell-Free DNA Polymerase Chain Reaction Over Serum Galactomannan for the Diagnosis of Invasive Aspergillosis
- 14 July 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 77 (9) , 1282-1290
Abstract
Invasive aspergillosis (IA) in immunocompromised hosts carries a high morbidity and mortality. Diagnosis is often delayed as definitive diagnosis requires invasive specimen collection while non-invasive testing with galactomannan is moderately accurate. Plasma cell-free DNA PCR represents a novel testing modality for the non-invasive diagnosis of invasive fungal disease (IFD). We directly compared the performance of Aspergillus plasma cfDNA PCR to serum galactomannan for the diagnosis of IFA during routine clinical practice. We conducted a retrospective study of all patients with suspected IFD who had Aspergillus plasma cfDNA PCR testing at Stanford Health Care from September 1st, 2020 – October 30th, 2022. Patients were categorized into proven, probable, possible and no IA based on the EORTC/MSG 2020 definitions. Primary outcomes included the clinical sensitivity and specificity for Aspergillus plasma cfDNA PCR and galactomannan. Overall, 238 unique patients with Aspergillus plasma cfDNA PCRs test results, including 63 positives and 175 non-consecutive negatives, were included in this study. Majority were immunosuppressed (89.9%) with a 22.3% 30-day all-cause mortality. The overall sensitivity and specificity of Aspergillus plasma cfDNA PCR was 86.0% (37/43; 95% CI, 72.7-95.7) and 93.1% (121/130; 95% CI, 87.4-96.3). The sensitivity and specificity of serum galactomannan in hematologic malignancies/stem cell transplants was 67.9% (19/28; 95% CI, 49.3-82.1) and 89.8% (53/59; 95% CI, 79.5-95.3), respectively. The sensitivity of cfDNA PCR was 93.0% (40/43; 95% CI, 80.9-98.5) in patients with a new diagnosis of IA. Aspergillus plasma cfDNA PCR represents a more sensitive alternative to serum galactomannan for non-invasive diagnosis of IA.Keywords
This publication has 43 references indexed in Scilit:
- Multicenter Comparison of Serum and Whole-Blood Specimens for Detection of Aspergillus DNA in High-Risk Hematological PatientsJournal of Clinical Microbiology, 2013
- Evaluation of Real-Time PCR, Galactomannan Enzyme-Linked Immunosorbent Assay (ELISA), and a Novel Lateral-Flow Device for Diagnosis of Invasive AspergillosisJournal of Clinical Microbiology, 2013
- A Novel Extraction Method Combining Plasma with a Whole-Blood Fraction Shows Excellent Sensitivity and Reproducibility for Patients at High Risk for Invasive AspergillosisJournal of Clinical Microbiology, 2012
- Aspergillus PCR: One Step Closer to StandardizationJournal of Clinical Microbiology, 2010
- Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCTBone Marrow Transplantation, 2010
- Detection of CirculatingAspergillus fumigatusDNA by Real-Time PCR Assay of Large Serum Volumes Improves Early Diagnosis of Invasive Aspergillosis in High-Risk Adult Patients under Hematologic SurveillanceJournal of Clinical Microbiology, 2008
- Prospective Evaluation of a Polymerase Chain Reaction–ELISA Targeted toAspergillus fumigatusandAspergillus flavusfor the Early Diagnosis of Invasive Aspergillosis in Patients with Hematological MalignanciesThe Journal of Infectious Diseases, 2006
- Polymerase Chain Reaction for Diagnosing Invasive Aspergillosis: Getting Closer but Still a Ways to GoClinical Infectious Diseases, 2006
- A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patientsBone Marrow Transplantation, 2005
- Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factorsBlood, 2002